Skip to main content

Dyne Therapeutics, Inc.

DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001818794

In the last 90 days, Dyne Therapeutics, Inc. insiders filed 1 open-market purchase and 7 sales; 269 institutions reported holding it in 13F filings for Q3 2026, worth $3.44B in total; Soros Fund Management is the only superinvestor holding it.

Politicians who traded DYN

No member of Congress has reported a trade in Dyne Therapeutics, Inc. shares or options since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.